Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gilead Sciences

114.51
+1.331.18%
Post-market: 113.30-1.2100-1.06%18:23 EDT
Volume:5.63M
Turnover:642.46M
Market Cap:142.44B
PE:24.21
High:114.57
Open:113.45
Low:113.23
Close:113.18
Loading ...

Gilead Sciences Inc. Stock Rises Monday, Still Underperforms Market

Dow Jones
·
1 hour ago

Gilead Sciences Updates Bylaws to Enhance Director Nomination and Meeting Procedures

Reuters
·
2 hours ago

Gilead Sciences Reports Earnings Thursday. Can The Highly Ranked Drugmaker Beat Its 237% Profit Surge Last Quarter?

Blockhead
·
4 hours ago

Gilead Sciences Completes Promising Phase III Study on Urothelial Cancer Treatment

TIPRANKS
·
6 hours ago

Trump posts letters calling on drug company CEOs to lower prices

TIPRANKS
·
01 Aug

Gilead Sciences Advances Pediatric Hepatitis B Treatment with TAF Study Update

TIPRANKS
·
01 Aug

FDA Approves New Biktarvy Indication for Treatment-Experienced People With HIV Restarting Antiretroviral Therapy, Announces Gilead Sciences Inc

Reuters
·
31 Jul

Gilead Sciences Inc. CEO Daniel O'Day Reports Disposal of Common Shares

Reuters
·
30 Jul

Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
30 Jul

Hookipa Pharma Inc. Conducted Special Stockholder Meeting to Vote on Key Proposals

Reuters
·
30 Jul

Gilead Sciences’ Strategic Positioning and Growth Prospects in the HIV Prevention Market Justify Buy Rating

TIPRANKS
·
29 Jul

Why Gilead Sciences Stock Slipped Today

Motley Fool
·
29 Jul

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2025-07-28

Reuters
·
28 Jul

Gilead Sciences Stock Surges Amid Promising Trials

TIPRANKS
·
26 Jul

Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
26 Jul

Why Gilead Sciences Stock Just Popped

Motley Fool
·
26 Jul

Needham Upgrades Gilead Sciences to Buy From Hold, Price Target is $133

MT Newswires Live
·
25 Jul

Gilead upgraded to Buy from Hold at Needham

TIPRANKS
·
25 Jul

Gilead : Needham Raises to Buy From Hold

THOMSON REUTERS
·
25 Jul

Gilead announces CHMP opinion recommending lenacapavir

TIPRANKS
·
25 Jul